Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000273962 | SCV000337279 | uncertain significance | not provided | 2015-11-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001088051 | SCV000644592 | benign | Tuberous sclerosis 2 | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000273962 | SCV001885529 | benign | not provided | 2019-06-21 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001088051 | SCV002040241 | likely benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002338841 | SCV002640749 | likely benign | Hereditary cancer-predisposing syndrome | 2020-06-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV003995772 | SCV004828707 | likely benign | Tuberous sclerosis syndrome | 2023-09-17 | criteria provided, single submitter | clinical testing |